A comprehensive view of Clinical Trials. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Efforts are ongoing to rescue gene therapy for rare disease ADA-SCiD; researchers at UCL and UCLA are developing the non-FDA approved simoladagene autotemcel therapy, supported by nonprofits
Published: July 26, 2024 by MarketLine
Johnson & Johnson offers $250K grant to promote diversity in clinical trials; initiative focuses on immune-mediated diseases and provides access to JLABS network and mentorship opportunities
Published: July 26, 2024 by Industry Intelligence Inc.
Bristol-Myers Squibb advances healthcare with CAR T therapy trials; company supports patient accessibility with travel aid for lupus study participants, emphasizing commitment to equitable treatment
Published: July 26, 2024 by Industry Intelligence Inc.
Eisai and Biogen disappointed by EMA's negative opinion on lecanemab for early Alzheimer's; the humanized anti-amyloid-beta monoclonal antibody was under review for mild cognitive impairment
Published: July 26, 2024 by Biogen Inc.
Merck receives positive EU CHMP opinion for KEYTRUDA and Padcev for first-line treatment of unresectable or metastatic urothelial carcinoma; based on Phase 3 KEYNOTE-A39 trial results
Published: July 26, 2024 by Merck & Co. Inc.

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count